Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns
(NASDAQ: FULC) Delayed: 3.85 +0.01 (0.26%)
Previous Close $3.84    52 Week High $ 
Open $3.81    52 Week Low $ 
Day High $3.86    P/E N/A 
Day Low $3.80    EPS $ 
Volume 470,208